Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04195594
Other study ID # 19KLHT
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 14, 2020
Est. completion date October 13, 2020

Study information

Verified date April 2021
Source TRC GEN+ managed by Trans Russian co Cy
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The present study will investigate the effects of Nic's Ketogenic diet, comprised of 70% fat, 5% carbohydrate, and 25% protein on middle-aged males and females with mid-range elevated LDL. With the mixed evidence on the causative effect of LDL cholesterol on increased cardiovascular health risk, further studies are warranted to examine the relation of elevated LDL and other biomarkers of cardiovascular health in response to a lifestyle intervention. Furthermore, this study will investigate weight loss and body composition changes with adherence to this dietary intervention over a 140-day period. In this study the efficacy of Nic's Ketogenic diet on weight loss and biomarkers of cardiovascular health will be examined.


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date October 13, 2020
Est. primary completion date October 13, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 30 Years to 55 Years
Eligibility Inclusion Criteria: 1. Provided voluntary, written, informed consent to participate in study 2. Males and females between 30 and 55 years of age 3. BMI between 20.0 to 29.9 kg/m2, inclusive 4. Female participant is not of child-bearing potential, defined as females who have undergone a sterilization procedure (e.g. hysterectomy, bilateral oophorectomy, bilateral tubal ligation, total endometrial ablation) Or, Females of child-bearing potential must have a negative baseline urine pregnancy test and agree to use a medically approved method of birth control for the duration of the study. Acceptable methods of birth control include: - Non hormonal contraceptives - Double-barrier method - Intrauterine devices - Non-heterosexual lifestyle or agrees to use contraception if planning on changing to heterosexual partner(s) - Vasectomy of partner at least 6 months prior to screening 5. Subjects with mid-range (2.5-4.1mmol/L or 100-159 mg/dL) elevated LDL-C levels 6. Agrees to maintain current level of physical activity throughout the study 7. Willingness to complete all questionnaires, records, and diaries and assessments associated with the study and to complete all clinic visits. 8. Healthy as determined by medical history, laboratory results, and as assessed by Qualified Investigator (QI) Exclusion Criteria: 1. Women who are pregnant, breast feeding, or planning to become pregnant during the course of the trial 2. Women who are menopausal or post-menopausal 3. Currently following a diet (i.e. Ketogenic Diet, low-carbohydrate diet) 4. Subjects with high TSH level (>4.5mU/L) or Self reported pre-existing thyroid condition. Treatment on a stable dose of medication for at least 3 months will be considered by the QI 5. Participants with type I or II Diabetes Mellitus 6. Cancer, except skin cancers completely excised with no chemotherapy or radiation with a follow up that is negative. Volunteers with cancer in full remission for more than five years after diagnosis are acceptable. 7. Participants with previous or current pathology of the pancreas 8. Current or history of Gastroesophageal reflux disease (GERD) or any significant disease of the gastrointestinal tract 9. Self reported hypertension or on hypertensives. 10. Significant cardiovascular event in the past 6 months as assessed by the QI. 11. Major surgery in the past 3 months or individuals who have planned surgery during the course of the trial. Participants with minor surgery will be considered on a case-by-case basis by the QI 12. Gastric bypass surgery 13. Individuals with an autoimmune disease or are immune-compromised 14. Self reported HIV-, Hepatitis B- and/or C-positive diagnosis 15. History of or current diagnosis with kidney and/or liver diseases as assessed by the QI on a case-by-case basis, with the exception of history of kidney stones symptom free for 6 months 16. Self reported medical or neuropsychological condition and/or cognitive impairment that, in the QI's opinion, could interfere with study participation 17. Self reported blood/bleeding disorders as per QI 18. Current use of prescribed medications listed in Section 7.3.1 19. Current use of over-the-counter medications, supplements, foods, and/or drinks listed in Section 7.3.2 20. Alcohol or drug abuse within the last 12 months 21. High alcohol intake (>2 standard drinks per day or >10 standard drinks per week) 22. Clinically significant abnormal laboratory results at screening as assessed by the QI 23. Metal implants that may affect the DEXA scan results will be assessed on case-by-case basis by the QI 24. Blood donation 30 days prior to screening, during the study, or a planned donation within 30-days of the last study visit 25. Participation in a clinical research trial within 30 days of study initiation 26. Individuals who are unable to give informed consent 27. Any other active or unstable medical condition, that, in the opinion of the QI, may adversely affect the participant's ability to complete the study or its measures or may pose significant risk to the participant

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Nic's Keto Diet
Participants will be instructed to follow Nic's keto diet plan for 140 days. They will be asked to not exceed 20 g of carbohydrates (up to 5% caloric intake) and to consume the remaining 70% of calories from fat sources and 25% from protein sources.

Locations

Country Name City State
Canada KGK Science Inc. London Ontario

Sponsors (2)

Lead Sponsor Collaborator
TRC GEN+ managed by Trans Russian co Cy KGK Science Inc.

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Other Number of Pre-emergent and Post-emergent Adverse Events Number of pre-emergent and post-emergent adverse events (AEs) 140 days
Other Number of Participants With Abnormal Electrocardiogram (ECG) Readings After 70 Days Following Nic's Keto Diet ECG reports will be analysed after 70 days of following Nic's Keto Diet and compared to baseline. All ECGs will be assessed by the Qualified Investigator on a case-by-case basis to determine if they were normal or abnormal based on the full clinical picture and patient details. Number of participants with clinically relevant abnormal ECGs will be recorded. 70 days
Other Number of Participants With Abnormal Electrocardiogram (ECG) Readings After 140 Days Following Nic's Keto Diet ECG reports will be analysed after 140 days of following Nic's Keto Diet and compared to baseline. All ECGs will be assessed by the Qualified Investigator on a case-by-case basis to determine if they were normal or abnormal based on the full clinical picture and patient details. Number of participants with clinically relevant abnormal ECGs will be recorded. 140 days
Other Change in Heart Rate After 140 Days of Following Nic's Keto Diet Changes in heart rate after 140 days of following Nic's Keto Diet and compared to baseline. 140 days
Other Change in Body Mass Index (BMI) After 140 Days of Following Nic's Keto Diet Change in Body Mass Index (BMI) after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Alanine Aminotransferase (ALT) After 140 Days of Following Nic's Keto Diet Change in alanine aminotransferase (ALT) after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Aspartate Aminotransferase (AST) After 140 Days of Following Nic's Keto Diet Change in aspartate aminotransferase (AST) after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Total Bilirubin After 140 Days of Following Nic's Keto Diet Change in total bilirubin after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Creatinine After 140 Days of Following Nic's Keto Diet Change in creatinine after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Sodium Electrolyte Levels After 140 Days of Following Nic's Keto Diet Change in sodium electrolyte levels after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Potassium Electrolyte Levels After 140 Days of Following Nic's Keto Diet Change in potassium electrolyte levels after 140 days of following Nic's Keto Diet 140 days
Other Change in Chloride Electrolyte Levels After 140 Days of Following Nic's Keto Diet Change in chloride electrolyte levels after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Phosphorus Electrolyte Levels After 140 Days of Following Nic's Keto Diet Change in phosphorus electrolyte levels after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Estimated Glomerular Filtration Rate (eGFR) After 140 Days of Following Nic's Keto Diet Change in estimated glomerular filtration rate (eGFR) after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Amount of Neutrophils After 140 Days of Following Nic's Keto Diet Change in amount of neutrophils after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Amount of Lymphocytes After 140 Days of Following Nic's Keto Diet Change in amount of lymphocytes after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Amount of Monocytes After 140 Days of Following Nic's Keto Diet Change in amount of monocytes after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Amount of Eosinophils After 140 Days of Following Nic's Keto Diet Change in amount of eosinophils after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Amount of Basophils After 140 Days of Following Nic's Keto Diet Change in amount of basophils after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Red Blood Cell (RBC) Count After 140 Days of Following Nic's Keto Diet Change in red blood cell (RBC) count after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Hemoglobin Levels After 140 Days of Following Nic's Keto Diet Change in hemoglobin levels after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Hematocrit Levels After 140 Days of Following Nic's Keto Diet Change in hematocrit levels after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Platelet Count After 140 Days of Following Nic's Keto Diet Change in platelet count after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Mean Corpuscular Volume (MCV) After 140 Days of Following Nic's Keto Diet Change in mean corpuscular volume (MCV) after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Mean Corpuscular Hemoglobin (MCH) After 140 Days of Following Nic's Keto Diet Change in mean corpuscular hemoglobin (MCH) after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Mean Corpuscular Hemoglobin Concentration (MCHC) After 140 Days of Following Nic's Keto Diet Change in mean corpuscular hemoglobin concentration (MCHC) after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Red Cell Distribution Width (RDW) After 140 Days of Following Nic's Keto Diet Change in red cell distribution width (RDW) after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Other Change in Mean Platelet Volume (MPV) After 140 Days of Following Nic's Keto Diet Change in mean platelet volume (MPV) after 140 days of following Nic's Keto Diet compared to baseline. 140 days
Primary Changes to Body Fat Percentage as Assessed by DEXA Scan From Baseline to Day 70 Following Nic's Keto Diet The DEXA scan is a form of X-ray radiation that measures the body tissue density, which was reported at baseline and compared to day 70. 70 days
Primary Changes to Muscle Mass Percentage as Assessed by DEXA Scan From Baseline to Day 70 Following Nic's Keto Diet The DEXA scan is a form of X-ray radiation that measures the body tissue density, which was reported at baseline and compared to day 70. 70 days
Primary Changes to Body Fat Percentage as Assessed by DEXA Scan From Baseline to Day 140 Following Nic's Keto Diet The DEXA scan is a form of X-ray radiation that measures the body tissue density, which was reported at baseline and compared to day 140. 140 days
Primary Changes to Muscle Mass Percentage as Assessed by DEXA Scan From Baseline to Day 140 Following Nic's Keto Diet The DEXA scan is a form of X-ray radiation that measures the body tissue density, which was reported at baseline and compared to day 140. 140 days
Primary Changes to Weight as Assessed by BMI From Baseline to Day 70 Following Nic's Keto Diet Changes to weight as assessed by BMI was reported at baseline and compared to day 70. 70 days
Primary Changes to Weight as Assessed by BMI From Baseline to Day 140 Following Nic's Keto Diet Changes to weight as assessed by BMI was reported at baseline and compared to day 140. 140 days
Secondary The Change in Inflammation, as Assessed by the Change in Erythrocyte Sedimentation Rate (ESR) Following Nic's Keto Diet for 140 Days The change in inflammation, as assessed by the change in erythrocyte sedimentation rate (ESR) following Nic's Keto Diet was reported at 140 days. 140 days
Secondary The Change in Inflammation, as Assessed by the Change in C-reactive Protein (CRP) Following Nic's Keto Diet for 140 Days The change in inflammation, as assessed by the change in C-reactive protein (CRP) following Nic's Keto Diet was reported at 140 days. 140 days
Secondary Changes to Weight From Baseline to Day 28 Following Nic's Keto Diet Changes to weight from baseline were reported and compared to day 28 following Nic's Keto Diet. 28 days
Secondary Changes to Weight From Baseline to Day 56 Following Nic's Keto Diet Changes to weight from baseline were reported and compared to day 56 following Nic's Keto Diet. 56 days
Secondary Changes to Weight From Baseline to Day 84 Following Nic's Keto Diet Changes to weight from baseline were reported and compared to day 84 following Nic's Keto Diet. 84 days
Secondary Changes to Weight From Baseline to Day 112 Following Nic's Keto Diet Changes to weight from baseline were reported and compared to day 112 following Nic's Keto Diet. 112 days
Secondary Changes to Systolic Blood Pressure From Baseline to Day 28 Following Nic's Keto Diet Changes to systolic blood pressure from baseline were reported and compared to day 28 following Nic's Keto Diet. 28 days
Secondary Changes to Systolic Blood Pressure From Baseline to Day 56 Following Nic's Keto Diet Changes to systolic blood pressure from baseline were reported and compared to day 56 following Nic's Keto Diet. 56 days
Secondary Changes to Systolic Blood Pressure From Baseline to Day 84 Following Nic's Keto Diet Changes to systolic blood pressure from baseline were reported and compared to day 84 following Nic's Keto Diet. 84 days
Secondary Changes to Systolic Blood Pressure From Baseline to Day 112 Following Nic's Keto Diet Changes to systolic blood pressure from baseline were reported and compared to day 112 following Nic's Keto Diet. 112 days
Secondary Changes to Systolic Blood Pressure From Baseline to Day 140 Following Nic's Keto Diet Changes to systolic blood pressure from baseline were reported and compared to day 140 following Nic's Keto Diet. 140 days
Secondary Changes to Total Cholesterol From Baseline to Day 28 Following Nic's Keto Diet Changes to total cholesterol were reported from baseline and compared to day 28 following Nic's Keto diet using blood analysis (units in mmol/L) 28 days
Secondary Changes to Triglyceride Level From Baseline to Day 28 Following Nic's Keto Diet Changes to triglyceride level were reported from baseline and compared to day 28 following Nic's Keto diet using blood analysis (units in mmol/L). 28 days
Secondary Changes to HDL-Cholesterol From Baseline to Day 28 Following Nic's Keto Diet Changes to HDL-cholesterol from baseline to day 28 were reported following Nic's Keto diet using blood analysis (units in mmol/L). 28 days
Secondary Changes to LDL-Cholesterol From Baseline to Day 28 Following Nic's Keto Diet Changes to LDL-cholesterol from baseline to day 28 were reported following Nic's Keto diet using blood analysis (units in mmol/L). 28 days
Secondary Changes to Total Cholesterol From Baseline to Day 56 Following Nic's Keto Diet Changes to total cholesterol from baseline to day 56 were reported following Nic's Keto diet using blood analysis (units in mmol/L). 56 days
Secondary Changes to Triglyceride Level From Baseline to Day 56 Following Nic's Keto Diet Changes to triglyceride level from baseline to day 56 were reported following Nic's Keto diet using blood analysis (units in mmol/L). 56 days
Secondary Changes to HDL-Cholesterol From Baseline to Day 56 Following Nic's Keto Diet Changes to HDL-Cholesterol from baseline to day 56 were reported following Nic's Keto diet using blood analysis (units in mmol/L). 56 days
Secondary Changes to LDL-Cholesterol From Baseline to Day 56 Following Nic's Keto Diet Changes to LDL-Cholesterol from baseline to day 56 were reported following Nic's Keto diet using blood analysis (units in mmol/L). 56 days
Secondary Changes to Total Cholesterol From Baseline to Day 84 Following Nic's Keto Diet Changes to total cholesterol from baseline to day 84 were reported following Nic's Keto diet using blood analysis (units in mmol/L). 84 days
Secondary Changes to Triglyceride Level From Baseline to Day 84 Following Nic's Keto Diet Changes to triglyceride level from baseline to day 84 were reported following Nic's Keto diet using blood analysis (units in mmol/L). 84 days
Secondary Changes to HDL-Cholesterol From Baseline to Day 84 Following Nic's Keto Diet Changes to HDL-Cholesterol from baseline to day 84 were reported following Nic's Keto diet using blood analysis (units in mmol/L). 84 days
Secondary Changes to LDL-Cholesterol From Baseline to Day 84 Following Nic's Keto Diet Changes to LDL-Cholesterol from baseline to day 84 were reported following Nic's Keto diet using blood analysis (units in mmol/L). 84 days
Secondary Changes to Total Cholesterol From Baseline to Day 112 Following Nic's Keto Diet Changes to total cholesterol from baseline to day 112 were reported following Nic's Keto diet using blood analysis (units in mmol/L). 112 days
Secondary Changes to Triglyceride Level From Baseline to Day 112 Following Nic's Keto Diet Changes to triglyceride level from baseline to day 112 were reported following Nic's Keto diet using blood analysis (units in mmol/L). 112 days
Secondary Changes to HDL-Cholesterol From Baseline to Day 112 Following Nic's Keto Diet Changes to HDL-Cholesterol from baseline to day 112 were reported following Nic's Keto diet using blood analysis (units in mmol/L). 112 days
Secondary Changes to LDL-Cholesterol From Baseline to Day 112 Following Nic's Keto Diet Changes to LDL-Cholesterol from baseline to day 112 were reported following Nic's Keto diet using blood analysis (units in mmol/L). 112 days
Secondary Changes to Total Cholesterol From Baseline to Day 140 Following Nic's Keto Diet Changes to total cholesterol from baseline to day 140 were reported following Nic's Keto diet using blood analysis (units in mmol/L). 140 days
Secondary Changes to Triglyceride Level From Baseline to Day 140 Following Nic's Keto Diet Changes to triglyceride level from baseline to day 140 were reported following Nic's Keto diet using blood analysis (units in mmol/L). 140 days
Secondary Changes to HDL-Cholesterol From Baseline to Day 140 Following Nic's Keto Diet Changes to HDL-Cholesterol from baseline to day 140 were reported following Nic's Keto diet using blood analysis (units in mmol/L). 140 days
Secondary Changes to LDL-Cholesterol From Baseline to Day 140 Following Nic's Keto Diet Changes to LDL-Cholesterol from baseline to day 140 were reported following Nic's Keto diet using blood analysis (units in mmol/L). 140 days
Secondary Changes to HbA1c From Baseline to Day 140 Following Nic's Keto Diet Changes to HbA1c were reported at baseline and compared to day 140 following Nic's Keto Diet. 140 days
Secondary Changes to Fasting Glucose From Baseline to Day 140 Following Nic's Keto Diet Changes to fasting glucose were reported at baseline and compared to day 140 following Nic's Keto Diet. 140 days
Secondary Changes to Free Tri-iodothyronine (T3) From Baseline to Day 140 Following Nic's Keto Diet Changes to free tri-iodothyronine (T3) were reported at baseline and compared to day 140 following Nic's Keto Diet. 140 days
Secondary Changes to Weight From Baseline to Day 70 Following Nic's Keto Diet Changes to weight were reported from baseline and compared to day 70 following Nic's Keto Diet. 70 days
Secondary Changes to Weight From Baseline to Day 140 Following Nic's Keto Diet Changes to weight were reported from baseline and compared to Day 140 following Nic's Keto Diet. 140 days
Secondary Changes to Systolic Blood Pressure From Baseline to Day 70 Following Nic's Keto Diet Changes to systolic blood pressure were reported from baseline and compared to Day 70 following Nic's Keto Diet. 70 days
Secondary Changes to Diastolic Blood Pressure From Baseline to Day 28 Following Nic's Keto Diet Changes to diastolic blood pressure were reported from baseline and compared to Day 28 following Nic's Keto Diet. 28 days
Secondary Changes to Diastolic Blood Pressure From Baseline to Day 56 Following Nic's Keto Diet Changes to diastolic blood pressure were reported from baseline and compared to Day 56 following Nic's Keto Diet. 56 days
Secondary Changes to Diastolic Blood Pressure From Baseline to Day 70 Following Nic's Keto Diet Changes to diastolic blood pressure were reported from baseline and compared to Day 70 following Nic's Keto Diet. 70 days
Secondary Changes to Diastolic Blood Pressure From Baseline to Day 84 Following Nic's Keto Diet Changes to diastolic blood pressure were reported from baseline and compared to Day 84 following Nic's Keto Diet. 84 days
Secondary Changes to Diastolic Blood Pressure From Baseline to Day 112 Following Nic's Keto Diet Changes to diastolic blood pressure were reported from baseline and compared to Day 112 following Nic's Keto Diet. 112 days
Secondary Changes to Diastolic Blood Pressure From Baseline to Day 140 Following Nic's Keto Diet Changes to diastolic blood pressure were reported from baseline and compared to Day 140 following Nic's Keto Diet. 140 days
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1